Alimera Sciences (ALIM)

Alimera (ALIM) Stock Price & Analysis


ALIM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.30 - $7.92
Previous Close$1.95
Average Volume (3M)21.34K
Market Cap
Enterprise Value$70.81M
Total Cash (Recent Filing)$5.51M
Total Debt (Recent Filing)$44.13M
Price to Earnings (P/E)-0.7
Mar 31, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding7,008,482
10 Day Avg. Volume12,496
30 Day Avg. Volume21,344
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-0.25
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)32.80
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit1.36
Enterprise Value/Ebitda-6.98
Price Target Upside361.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Alimera Sciences’s price range in the past 12 months?
Alimera Sciences lowest stock price was $1.30 and its highest was $7.92 in the past 12 months.
    What is Alimera Sciences’s market cap?
    Currently, no data Available
    When is Alimera Sciences’s upcoming earnings report date?
    Alimera Sciences’s upcoming earnings report date is Mar 31, 2023 which is in 2 days.
      How were Alimera Sciences’s earnings last quarter?
      Alimera Sciences released its earnings results on Nov 14, 2022. The company reported -$0.75 earnings per share for the quarter, missing the consensus estimate of -$0.4 by -$0.35.
        Is Alimera Sciences overvalued?
        According to Wall Street analysts Alimera Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Alimera Sciences pay dividends?
          Alimera Sciences does not currently pay dividends.
          What is Alimera Sciences’s EPS estimate?
          Alimera Sciences’s EPS estimate is -$0.34.
            How many shares outstanding does Alimera Sciences have?
            Alimera Sciences has 7,008,482 shares outstanding.
              What happened to Alimera Sciences’s price movement after its last earnings report?
              Alimera Sciences reported an EPS of -$0.75 in its last earnings report, missing expectations of -$0.4. Following the earnings report the stock price went down -2.008%.
                Which hedge fund is a major shareholder of Alimera Sciences?
                Among the largest hedge funds holding Alimera Sciences’s share is Blackstone Inc.. It holds Alimera Sciences’s shares valued at N/A.


                  Alimera Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Alimera Sciences

                  Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.


                  Top 5 ETFs holding ALIM

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold ALIM. The ETFs are listed according to market value of ALIM within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Lowell Farms
                  Zynerba Pharmaceuticals
                  Real Brands
                  Angion Biomedica
                  PaxMedica, Inc.

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis